Over 400 Total Lots Up For Auction at Two Locations - NJ 05/08, WA 05/09

TransMed7, LLC announces 510(k) clearance by the U.S. FDA for its Concorde US and Concorde ST soft tissue biopsy device

Press releases may be edited for formatting or style | September 01, 2020 Operating Room Ultrasound


About TransMed7, LLC
TransMed7, LLC is a medical and technology-based organization focused on the highly efficient development of innovative, minimally-invasive medical devices aimed at providing new solutions for doctors and their patients. With particular expertise in oncologic, regenerative, and cardiovascular disease, TransMed7 and its team of clinicians, scientists, and engineers have developed a portfolio of next-generation platform devices that are expected to be market leaders in their targeted fields of medicine. TransMed7 accomplishes this through application of a wholly new approach in its business plan and structure, enabling these new transformational technologies from rapid development through commercial manufacturing or where appropriate, handoff to our Strategic Partners.

Back to HCB News

You Must Be Logged In To Post A Comment